Announced Wed, 24 Jun · 11:09 IST
Trading Window Closure from July 1, 2026 for Q1 FY27 Results
Compliance View source PDF
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.1%1-day move
₹707.00
prior close
₹711.95
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.3+0.2+0.5-1.1-4.1-3.8-0.7-0.6-0.6+0.8-4.5——
Up moveDown movePending
AI summary
Aarti Pharmalabs has closed its trading window for insiders from July 1, 2026 until 48 hours after the company declares its financial results for the quarter ending June 30, 2026. This is a routine compliance measure under SEBI's Insider Trading Regulations to prevent designated persons from trading during the results period. The board meeting date to approve the Q1 FY27 results will be communicated in due course.
Likely market impact
Routine compliance measure. Insiders cannot trade till results are declared. Signals upcoming Q1 results announcement. Neutral for stock price.